CU71 R01
Alternative Names: CU-07; CU71-R01Latest Information Update: 30 Aug 2023
At a glance
- Originator CURACLE
- Class Cardiovascular therapies; Small molecules
- Mechanism of Action Endothelial cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cardiovascular disorders
Most Recent Events
- 05 Jul 2023 Early research in Cardiovascular disorders in South Korea (PO) before July 2023 (Curacle pipeline, July 2023)